Our Blog:

30 years of cell culture excellence

Author: Biological Industries

2016 BI-USA Year in Review

As 2016 comes to a close, we want to take this opportunity to extend our gratitude for our great new relationships. Whether you are a customer or a friend of BI and BI-USA, we appreciate the trust that you have placed in us and the opportunity to work with you throughout all of 2016. We were thrilled to announce our new US division at the end of 2015 (Biological Industries USA, Inc.). With one year under our belt, here are a few exciting highlights from our first full year: In the first quarter, BI-USA hosted several state representatives, local government,...

Read More

Biological Industries announces FDA Drug Master File Acceptance for NutriStem® hPSC XF Medium

KIBBUTZ BEIT HAEMEK, Israel and CROMWELL, CT, USA –  November 30, 2016 – Biological Industries (“BI”) announced today that the United States Food and Drug Administration (FDA) has accepted the submission for its Drug Master File (DMF) for the company’s NutriStem® hPSC XF Medium, a chemically defined, xeno-free, serum-free media, which is designed to support the growth of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). A Drug Master File (DMF) is a confidential detailed document submitted to the FDA by a manufacturer that includes the Chemistry, Manufacturing and Controls (CMC) information about their product. An...

Read More

Mycoplasma Contamination Infographic

It’s every researcher’s worst nightmare – mycoplasma contamination. First isolated in the 1950’s, it is estimated that about 35% of cell cultures used in research today are now infected.  According to publications, anywhere from 10 to 85% of cell lines may be contaminated, depending on the laboratory. It remains a common problem wherever lab space is shared, cell lines change hands, researchers come and go, and training in sterile techniques vary.  Below is an infographic that breaks down mycoplasma contamination facts and figures from publications around the world. Download this infographic or request a poster print by emailing...

Read More

Biological Industries Announces New Agreement with Mediatech, Inc., a Corning Subsidiary

Co-branding agreement of NutriStem® hPSC XF Medium for pluripotent stem cell culture to be commercialized by Corning June 22, 2016 CROMWELL, Conn. & KIBBUTZ BEIT HAEMEK, Israel–(BUSINESS WIRE)–Biological Industries (“BI”) announced today a co-branding agreement with Corning Incorporated’s subsidiary, Mediatech, Inc., which will enable cell therapy, research, and manufacturing organizations around the world to purchase the innovative, xeno-free NutriStem® human pluripotent stem cell (“hPSC”) medium in conjunction with Corning’s existing portfolio of stem cell-focused technologies. Before the end of this year, Corning and BI will launch a jointly-branded NutriStem&reg hPSC XF Medium, which will continue to be manufactured by...

Read More

Biological Industries to Participate at the ISSCR Annual Meeting 2016

Announces the launch of new xeno-free endothelial cell culture system suitable for clinical applications June 21, 2016 CROMWELL, Conn. & KIBBUTZ BEIT HAEMEK, Israel–(BUSINESS WIRE)–Biological Industries USA (“BI USA”; www.bioind.com), the US commercialization division of Biological Industries, a leading developer and manufacturer of cell culture media, molecular biology tools, human cytogenetics media, and custom media manufacturing services, will have a major presence at the International Society for Stem Cell Research (ISSCR) Annual Meeting, June 22-25 in San Francisco. “This year’s ISSCR meeting, co-sponsored by CIRM, promises to be the best one yet,” commented Tanya Potcova, CEO of BI USA....

Read More

Follow Us